Connection

David Smadja to Prospective Studies

Back to Details
This is a "connection" page, showing publications David Smadja has written about Prospective Studies.
David Smadja
Connection Strength
0.163
Prospective Studies
  1. Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 11; 73(11):1976-1985.
    View in: PubMed
    Score: 0.039
  2. Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. 2020 09; 18(9):2391-2399.
    View in: PubMed
    Score: 0.036
  3. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
    View in: PubMed
    Score: 0.035
  4. Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PLoS One. 2013; 8(6):e65114.
    View in: PubMed
    Score: 0.022
  5. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol. 2021; 12:701273.
    View in: PubMed
    Score: 0.010
  6. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One. 2021; 16(5):e0252026.
    View in: PubMed
    Score: 0.009
  7. Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month. PLoS One. 2018; 13(8):e0200364.
    View in: PubMed
    Score: 0.008
  8. Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation. J Cell Mol Med. 2010 Jan; 14(1-2):449-51.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.